An Observational Pre-post Study Evaluating the Safety of Tabernanthe Iboga Exposure

This is an observational study aiming to investigate the risks and consequences of naturalistic tabernanthe iboga exposure in a population with a history of head trauma, combat or blast exposure.

We will assess the safety profile of the compound through psychological and cognitive testing. Participants will also have an MRI before and after their exposure to the compound, to examine if there are any brain changes associated with its use. Participants must independently schedule to receive this compound in other countries.

Compound Ibogaine
Country United States of America
Visit trial
Status Not yet recruiting
Results Published
Start date 01 June 2020
End date 01 June 2023
Chance of happening 90%
Design Open
Type Observational
Generation First
Participants 30
Sex All
Age 18- 70
Therapy No

Trial Details

This is an observational study aiming to investigate the risks and consequences of naturalistic tabernanthe iboga exposure in a population with a history of head trauma, combat or blast exposure. We will assess the safety profile of the compound through psychological and cognitive testing. Participants will also have an MRI before and after their exposure to the compound, to examine if there are any brain changes associated with its use. Participants must independently schedule to receive this compound in other countries.

NCT Number NCT04313712

Sponsors & Collaborators

Stanford University
Researchers at Stanford are exploring the potential of ketamine, MDMA and psilocybin by connecting neuroscience, psychiatry and anesthesiology.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.